US Broker Ratings

McKesson Corporation (MCK) Stock Analysis: Potential 13.41% Upside with Robust Revenue Growth

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to capture investor attention with its compelling market dynamics and promising growth outlook. As a leader in medical distribution,..

BioNTech SE (BNTX) Stock Analysis: A 47% Upside Potential Amidst Promising Clinical Trials

BioNTech SE (NASDAQ: BNTX), headquartered in Mainz, Germany, has made waves in the biotechnology sector with its innovative approach to developing immunotherapies for cancer and infectious diseases. With a market..

Legend Biotech Corporation (LEGN): Analyst Consensus Highlights a Remarkable 220% Potential Upside

Legend Biotech Corporation (NASDAQ: LEGN) is carving a niche in the biotech sector with its innovative approach to oncology treatments. With a market capitalization of $4.16 billion, this Somerset, New..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring the 10.78% Upside Potential

Universal Health Services, Inc. (NYSE: UHS) is a prominent player in the healthcare sector, specializing in the operation of acute care hospitals and behavioral health care facilities. Headquartered in King..

Pfizer, Inc. (PFE) Investor Outlook: Evaluating a 14% Potential Upside and a Robust Dividend Yield

Pfizer, Inc. (NYSE: PFE) stands as a titan in the healthcare sector, best known for its significant contributions to drug manufacturing on a global scale. The company’s profile is marked..

Masimo Corporation (MASI) Stock Analysis: Exploring a 38% Potential Upside Amid Healthcare Innovations

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, is capturing investor interest with a potential upside of 38.41%. Despite recent market challenges, Masimo’s innovative strides in medical..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 11.67% Upside in the Booming Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, is making waves within the medical devices industry. With a robust market capitalization of $11.94 billion, this U.S.-based..

Repligen Corporation (RGEN) Stock Analysis: Exploring the 13.85% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, continues to capture the attention of investors. With a market capitalization..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Exploring the Biotech’s Precision Oncology Potential

Revolution Medicines, Inc. (RVMD) is making waves in the biotechnology sector with its pioneering approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution Medicines is focused on..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unlocking a 46.77% Upside Potential in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the healthcare sector, particularly within the medical device industry, as a promising investment opportunity. With a market capitalization of $2.82 billion,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Evaluating the $10.46 Billion TCM Innovator

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is carving out a niche in the healthcare sector with its focus on Traditional Chinese Medicine (TCM) aimed at treating neurocognitive disorders. Operating out..

HCA Healthcare, Inc. (HCA): Investor Outlook with Strong Revenue Growth and Analyst Consensus

HCA Healthcare, Inc. (NYSE: HCA) is a prominent name in the healthcare sector, operating an extensive network of medical care facilities across the United States. With a robust market capitalization..

Amgen Inc. (AMGN) Investor Outlook: Strong Revenue Growth and Robust Dividend Yield Highlight Investment Appeal

Amgen Inc. (NASDAQ: AMGN), a titan in the healthcare sector, continues to capture investor attention with its impressive revenue growth and robust dividend yield. As a leading player in the..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Close Look at Revenue Growth and Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a formidable player within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $15.99 billion, Medpace offers an extensive..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a 17.78% Upside Potential in the Biotechnology Sector

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the competitive biotechnology landscape with a compelling 17.78% potential upside, according to analyst ratings. This London-based clinical-stage biopharmaceutical company is making significant..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a Potential 13.53% Upside for Investors

Align Technology, Inc. (NASDAQ: ALGN) is a significant player in the healthcare sector, specializing in medical instruments and supplies. Best known for its Invisalign clear aligners, the company is a..

Guardant Health, Inc. (GH) Stock Analysis: A Precision Oncology Leader with Robust Growth Potential

Guardant Health, Inc. (NASDAQ: GH), a beacon of innovation in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with its strong revenue growth and potential upside...

Grifols, S.A. (GRFS) Stock Analysis: Unpacking a 21.98% Potential Upside Amid Healthcare Innovations

Grifols, S.A. (GRFS), a prominent player within the healthcare sector, stands as a key figure in the global plasma therapeutic space. With its headquarters nestled in Barcelona, Spain, Grifols operates..

Waystar Holding Corp. (WAY) Stock Analysis: A Promising 46.6% Upside in Healthcare Tech

Waystar Holding Corp. (WAY), a burgeoning entity in the healthcare sector, is drawing significant attention from investors with its innovative cloud-based software solutions for healthcare payments. Founded in 2017 and..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 19.43% Potential Upside in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is making waves in the biotechnology sector with its promising portfolio of treatments targeting central nervous system (CNS) disorders. Headquartered in New York, this biopharmaceutical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds